Vit D concentration associated with reduced risk of cancer

March 14, 2018

(HealthDay)—Higher plasma concentration of 25-hydroxyvitamin D is associated with reduced risk of total cancer in a Japanese population, according to a study published online March 7 in The BMJ.

Sanjeev Budhathoki, M.D., from the National Cancer Center in Tokyo, and colleagues examined the between pre-diagnostic circulating vitamin D concentration and the risk of . They performed a nested case-cohort study in which a total of 3,301 incident cases of cancer and 4,044 randomly selected subcohort participants within the Japan Public Health Center-based Prospective Study cohort were included.

The researchers found that there was an inverse correlation for 25-hydroxyvitamin D with the risk of total cancer, with multivariable adjusted hazard ratios of 0.81 (95 percent confidence interval [CI], 0.7 to 0.94), 0.75 (95 percent CI, 0.65 to 0.87), and 0.78 (95 percent CI, 0.67 to 0.91) for the second to fourth quarters versus the lowest quarter, respectively (P for trend = 0.001). There was also an inverse correlation for liver cancer, with corresponding hazard ratios of 0.7 (95 percent CI, 0.44 to 1.13), 0.65 (95 percent CI, 0.40 to 1.06), and 0.45 (95 percent CI, 0.26 to 0.79) (P for trend = 0.006). The overall hazard ratios were not substantially altered by removing cases of cancer at one specific site from total cancer cases.

"These findings support the hypothesis that vitamin D has protective effects against cancers at many sites," the authors write.

Fujirebio Inc. played a role in measurement of plasma 25-hydroxyvitamin D.

Explore further: Total, saturated fat linked to increased risk of lung cancer

More information: Abstract/Full Text

Related Stories

Total, saturated fat linked to increased risk of lung cancer

July 28, 2017
(HealthDay)—High intake of total and saturated fat is associated with increased risk of lung cancer, according to research published online July 25 in the Journal of Clinical Oncology.

25(OH)D levels linked to survival in pancreatic cancer

June 23, 2016
(HealthDay)—Prediagnostic 25-hydroxyvitamin D (25[OH]D) levels are associated with survival in pancreatic cancer, according to a study published online June 20 in the Journal of Clinical Oncology.

Soy food, isoflavone intake not linked to endometrial cancer

February 7, 2015
(HealthDay)—Soy food/isoflavone intake is not associated with endometrial cancer risk in Japanese women, according to a study published in the February issue of BJOG: An International Journal of Obstetrics & Gynaecology.

PPI-gastric cancer link remains after H. pylori eradication

November 2, 2017
(HealthDay)—Long-term proton pump inhibitor (PPI) use is associated with increased risk of gastric cancer (GC) even after Helicobacter pylori (HP) eradication therapy, according to a study published online Oct. 31 in Gut.

Stem cell factor tied to reduced risk of cardiac events, death

September 1, 2017
(HealthDay)—High levels of stem cell factor (SCF) are associated with reduced risk of mortality and cardiovascular events, according to a study published online Aug. 26 in the Journal of Internal Medicine.

Low vitamin D levels tied to increased cancer risk in IBD

May 6, 2014
(HealthDay)—Low plasma levels of 25-hydroxyvitamin D (25[OH]D) are associated with an increased risk of cancer in patients with inflammatory bowel diseases (IBD), according to a study published in the May issue of Clinical ...

Recommended for you

Ovarian cancer cells switched off by 'unusual' mechanism

June 19, 2018
Scientists at the Ovarian Cancer Action Research Centre at Imperial College London have discovered a mechanism that deactivates ovarian cancer cells.

Targeting the engine room of the cancer cell

June 18, 2018
Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug ...

Study suggests well-known growth suppressor actually fuels lethal brain cancers

June 18, 2018
Scientists report finding a potentially promising treatment target for aggressive and deadly high-grade brain cancers like glioblastoma. But they also say the current lack of a drug that hits the molecular target keeps it ...

Researchers create novel combination as potential therapy for high-risk neuroblastoma

June 18, 2018
Researchers at VCU Massey Cancer Center in Richmond, Virginia, have identified a promising target to reverse the development of high-risk neuroblastoma and potentially inform the creation of novel combination therapies for ...

Standard myelofibrosis drug can awaken 'dormant' lymphoma

June 18, 2018
Most patients with myelofibrosis, a rare chronic disorder of the haematopoietic cells of the bone marrow, benefit from drugs from the JAK2 inhibitor class: symptoms are relieved, survival extended and general quality-of-life ...

Genomics offers new treatment options for infants with range of soft tissue tumors

June 18, 2018
The genetic causes of a group of related infant cancers have been discovered by scientists at the Wellcome Sanger Institute, the University of Wuerzburg and their collaborators. Whole genome sequencing of tumours revealed ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.